June 13th 2025
Cemiplimab improved disease-free survival in patients with high-risk cutaneous squamous cell carcinoma (CSCC) and performed well in patients with advanced CSCC in the real-world setting.
Pre-Op Work Can Prevent Risks Associated With Morcellation: Study Finds
ASCO Members Take a Stand on Access to Care for Low-Income Individuals